Global Blood Therapeutics said to draw takeover interest, reveals Bloomberg

Global Blood Therapeutics, a US-listed biopharmaceutical company, is a business that has been on Betaville's radar for quite a few years amid vague rumours.

Now, though, arch rivals at Bloomberg are reporting that the company - which makes drugs for sickle cell disease - is working with advisers amid takeover interest from larger rivals.

Below is a link to the Bloomberg scoop, which has sent shares in Global Blood Therapeutics up 30pc overnight.....


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Thursday, 4 August 2022, 8:08 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation